321 related articles for article (PubMed ID: 37477762)
21. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
22. My time with Franz Enzinger at the Armed Forces Institute of Pathology.
Allen PW
Ann Diagn Pathol; 2022 Jun; 58():151914. PubMed ID: 35278805
[TBL] [Abstract][Full Text] [Related]
23. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.
Lai JP; Robbins PF; Raffeld M; Aung PP; Tsokos M; Rosenberg SA; Miettinen MM; Lee CC
Mod Pathol; 2012 Jun; 25(6):854-8. PubMed ID: 22388761
[TBL] [Abstract][Full Text] [Related]
24. Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.
Baranov E; Black MA; Fletcher CDM; Charville GW; Hornick JL
Mod Pathol; 2021 Jul; 34(7):1367-1372. PubMed ID: 33731886
[TBL] [Abstract][Full Text] [Related]
25. Differential diagnosis of myxoid soft tissue tumors. Experience in the Clinical University Hospital of Valencia.
Alfaro-Cervelló C; Nieto G; Navarro S
Rev Esp Patol; 2022; 55(3):185-191. PubMed ID: 35779885
[TBL] [Abstract][Full Text] [Related]
26. Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?
Ricci C; De Leo A; Dika E; Lambertini M; Veronesi G; Corti B
Acta Histochem; 2020 Feb; 122(2):151498. PubMed ID: 31889532
[TBL] [Abstract][Full Text] [Related]
27. Review of primary superficial soft tissue mesenchymal tumors of malignant or intermediate biological potential.
Oettel DJ; Bernard SA
Skeletal Radiol; 2023 Mar; 52(3):435-445. PubMed ID: 35867123
[TBL] [Abstract][Full Text] [Related]
28. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
29. Cytopathology of myxofibrosarcoma: a study of 66 cases and literature review.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):300-309. PubMed ID: 33041221
[TBL] [Abstract][Full Text] [Related]
30. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
31. The role of electron microscopy in the diagnosis of pleomorphic sarcomas of soft tissue.
Kindblom LG; Widéhn S; Meis-Kindblom JM
Semin Diagn Pathol; 2003 Feb; 20(1):72-81. PubMed ID: 12693676
[TBL] [Abstract][Full Text] [Related]
32. A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor.
Grogg KL; Macon WR; Kurtin PJ; Nascimento AG
Mod Pathol; 2005 Feb; 18(2):260-6. PubMed ID: 15467709
[TBL] [Abstract][Full Text] [Related]
33. Challenging epithelioid mesenchymal neoplasms: mimics and traps.
Cacciatore M; Dei Tos AP
Pathology; 2014 Feb; 46(2):126-34. PubMed ID: 24384587
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Nov; 29(11):1324-1334. PubMed ID: 27443513
[TBL] [Abstract][Full Text] [Related]
35. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
[TBL] [Abstract][Full Text] [Related]
36. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
Bahmad HF; Oh KS; Alexis J
J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Immunohistochemistry for Soft Tissue and Bone Tumors: An Update.
Schaefer IM; Hornick JL
Adv Anat Pathol; 2018 Nov; 25(6):400-412. PubMed ID: 30134255
[TBL] [Abstract][Full Text] [Related]
38. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
Koch MB; Shih IM; Weiss SW; Folpe AL
Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
